论文部分内容阅读
目的研究运用米非司酮治疗宫腔残留的疗效。方法对我院2009年5月-2011年6月收治的76例宫腔残留患者随机分为两组,对照组采取清宫术治疗,治疗组进行米非司酮口服治疗,7-15d后进行B超复查,记录患者的康复情况。结果治疗组治疗有效率94.7%,高于对照组的81.6%,治疗组并发症发生率0%,低于对照组的10.5%,差异有统计学意义(P<0.05)。结论运用米非司酮治疗宫腔残留,效果显著,能有效缓解患者痛苦,值得临床推广。
Objective To study the efficacy of mifepristone in the treatment of residual uterine cavity. Methods 76 cases of uterine cavity residual patients admitted to our hospital from May 2009 to June 2011 were randomly divided into two groups. The control group was treated with curettage. The treatment group was treated with mifepristone orally. After 7-15 days, Ultra-review, record the patient’s recovery. Results The effective rate of the treatment group was 94.7%, higher than that of the control group 81.6%. The incidence of complications in the treatment group was 0%, which was lower than 10.5% in the control group. The difference was statistically significant (P <0.05). Conclusion The use of mifepristone treatment of uterine cavity residue, the effect is significant, can effectively alleviate the suffering of patients, it is worth clinical promotion.